doi: 10.1210/clinem/dgaa863 Summary Keywords obesity, insulin-resistance, Tirzepatide, pathophysiology, GIP, GLP - 1, clinical trials, arterial hypertension Citation Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
Clinically, skin aging is manifested by visible changes such as wrinkles, laxity, and hyperpigmentation [34]
Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge
The term lipotropic refers to compounds that help the liver process and remove fat more efficiently
In short, NAD+ acts like a systemic battery and spark, while a peptide acts like a precise message to a chosen cell type